MARUS BRIDGE PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: P92642 | WIGAN, WN3 5HL
Showing results 351-400 of 512
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Safinamide | 25 | 1,194 | £2.6K | +24.1% ▲ |
| Brinzolamide/brimonidine | 25 | 270 | £474 | -27.1% ▼ |
| Adapalene | 25 | 2,430 | £843 | +14.2% ▲ |
| Ondansetron hydrochloride | 24 | 1,040 | £346 | -50.5% ▼ |
| Azathioprine | 24 | 1,008 | £22 | -77.9% ▼ |
| Anastrozole | 24 | 980 | £37 | -73.6% ▼ |
| Water for injection | 24 | 450 | £416 | -29.1% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 24 | 60.7K | £2.1K | -9.6% ▼ |
| 24 | 817 | £180 | -51.4% ▼ | |
| Fluvastatin sodium | 23 | 1,372 | £230 | -0.6% vs avg |
| Cenobamate | 23 | 630 | £3.7K | -5.1% ▼ |
| Acetic acid | 23 | 115 | £108 | +98.6% ▲ |
| 23 | 350 | £1.2K | -25.2% ▼ | |
| Ursodeoxycholic acid | 22 | 2,288 | £1.7K | -66.8% ▼ |
| Aclidinium bromide | 22 | 27 | £834 | -17.1% ▼ |
| Tapentadol | 22 | 1,652 | £910 | -46.6% ▼ |
| Estradiol valerate | 22 | 1,680 | £140 | +12.6% ▲ |
| Vitamin B compound | 22 | 1,456 | £43 | -84.2% ▼ |
| Terbinafine hydrochloride | 22 | 510 | £89 | -40.7% ▼ |
| Hepatitis A | 22 | 22 | £441 | -71.0% ▼ |
| Typhoid | 22 | 22 | £228 | -75.6% ▼ |
| 22 | 1,345 | £587 | +13.8% ▲ | |
| Umeclidinium bromide | 21 | 25 | £653 | -65.9% ▼ |
| Promazine hydrochloride | 21 | 1,068 | £780 | -60.2% ▼ |
| Flupentixol decanoate | 21 | 21 | £127 | +31.6% ▲ |
| Phenobarbital | 21 | 2,268 | £127 | -31.7% ▼ |
| Levonorgestrel | 21 | 2,100 | £53 | +158.3% ▲ |
| Other individually formulated bought in preparations | 21 | 1,130 | £136 | -35.7% ▼ |
| Nefopam hydrochloride | 20 | 1,496 | £66 | -82.3% ▼ |
| Terbinafine hydrochloride | 20 | 862 | £412 | -67.6% ▼ |
| Combined ethinylestradiol 20mcg | 20 | 1,098 | £287 | -61.7% ▼ |
| Sodium chloride | 20 | 3,032 | £275 | -15.5% ▼ |
| Midazolam hydrochloride | 20 | 186 | £105 | -51.1% ▼ |
| Hydroxyzine hydrochloride | 19 | 1,274 | £32 | -64.3% ▼ |
| Opicapone | 19 | 1,108 | £2.2K | -0.7% vs avg |
| Erythromycin | 19 | 1,576 | £617 | -45.2% ▼ |
| Dutasteride | 19 | 1,136 | £65 | -63.0% ▼ |
| 19 | 495 | £53 | -29.3% ▼ | |
| Zonisamide | 18 | 2,688 | £1.8K | -58.7% ▼ |
| Rotigotine | 18 | 854 | £3.6K | -33.3% ▼ |
| Trihexyphenidyl hydrochloride | 18 | 1,708 | £158 | -36.5% ▼ |
| Febuxostat | 18 | 1,064 | £165 | -51.8% ▼ |
| 18 | 605 | £54 | -63.9% ▼ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 17 | 784 | £113 | -51.1% ▼ |
| Labetalol hydrochloride | 17 | 1,288 | £101 | -25.1% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 17 | 2,094 | £231 | -57.7% ▼ |
| Saxagliptin | 17 | 588 | £631 | -49.1% ▼ |
| Cabergoline | 17 | 184 | £315 | +9.6% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 17 | 451.0K | £10.6K | +77.3% ▲ |
| Mefenamic acid | 17 | 646 | £119 | -62.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.